Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Milestone Pharmaceuticals Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +19 vs. Q2 2022
- Shares held
- 22.0M
- +1.15M (+5.5%) vs. Q2 2022
- Total value
- $198.7M
- +$71.5M (+56.2%) vs. Q2 2022
- New holders
- 21
- 9 more added
- Sold out
- 2
- 12 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 5 | $0 | 0.00% | +5 | New |
| The PNC Financial Services Group, Inc. | 137 | $1.00K | 0.00% | +137 | New |
| CSS LLC | 1,008 | $9.00K | 0.00% | +1,008 | New |
| Royal Bank of Canada | 2,000 | $18.0K | 0.00% | −16,500−89.2% | Reduced |
| Cowen and Company, LLC | 14,000 | $20.0K | 0.00% | +14,000 | New |
| Advisor Group Holdings, Inc. | 2,602 | $24.0K | 0.00% | −277−9.6% | Reduced |
| National Bank of Canada | 2,880 | $26.0K | 0.00% | −11,962−80.6% | Reduced |
| UBS Group AG | 3,320 | $31.0K | 0.00% | +2,304+226.8% | Added |
| Cutler Group LP | 3,937 | $36.0K | 0.00% | +3,937 | New |
| Group One Trading, L.P. | 4,248 | $39.0K | 0.00% | +4,248 | New |
| Federation des caisses Desjardins du Quebec | 10,500 | $96.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 11,499 | $106.0K | 0.00% | +11,499 | New |
| Cubist Systematic Strategies, LLC | 11,600 | $107.0K | 0.00% | +11,600 | New |
| Engineers Gate Manager LP | 11,800 | $108.0K | 0.01% | +11,800 | New |
| Geode Capital Management, LLC | 17,576 | $161.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,996 | $202.0K | 0.00% | +388+1.8% | Added |
| Caption Management, LLC | 25,378 | $233.0K | 0.04% | +25,378 | New |
| Fred Alger Management, LLC | 26,672 | $245.0K | 0.00% | +26,672 | New |
| Marshall Wace, LLP | 30,898 | $284.0K | 0.00% | +30,898 | New |
| LMR Partners LLP | 38,495 | $354.0K | 0.01% | +26,763+228.1% | Added |
| Susquehanna International Group, LLP | 46,308 | $426.0K | 0.00% | +28,075+154.0% | Added |
| Bank of Montreal | 48,100 | $446.0K | 0.00% | +48,100 | New |
| JPMorgan Chase & Co | 53,675 | $493.0K | 0.00% | +50,136+1,416.7% | Added |
| Ensign Peak Advisors, Inc | 69,422 | $638.0K | 0.00% | +69,422 | New |
| Bank of America Corp | 72,680 | $668.0K | 0.00% | +72,680 | New |
| Dimensional Fund Advisors LP | 73,274 | $673.0K | 0.00% | −2,072−2.7% | Reduced |
| Boothbay Fund Management, LLC | 73,752 | $678.0K | 0.02% | −58,749−44.3% | Reduced |
| Valeo Financial Advisors, LLC | 75,500 | $694.0K | 0.04% | +75,500 | New |
| Goldman Sachs Group Inc | 104,497 | $960.0K | 0.00% | +92,493+770.5% | Added |
| Eversept Partners, LP | 126,826 | $1.17M | 0.14% | −20,339−13.8% | Reduced |
| Bleichroeder LP | 512,500 | $4.71M | 0.98% | 00.0% | Unchanged |
| Barclays PLC | 540,582 | $4.97M | 0.01% | +328,872+155.3% | Added |
| Janus Henderson Group PLC | 560,168 | $5.14M | 0.00% | +560,168 | New |
| Pura Vida Investments, LLC | 596,531 | $5.48M | 0.83% | −390,880−39.6% | Reduced |
| Citadel Advisors LLC | 596,978 | $5.49M | 0.01% | +596,978 | New |
| Acuta Capital Partners, LLC | 597,026 | $5.49M | 2.44% | +139,826+30.6% | Added |
| Paradigm Biocapital Advisors LP | 634,211 | $5.83M | 0.82% | +634,211 | New |
| Great Point Partners LLC | 674,656 | $6.20M | 1.49% | +674,656 | New |
| Boxer Capital, LLC | 698,861 | $6.42M | 0.36% | −1,540,000−68.8% | Reduced |
| Ikarian Capital, LLC | 855,616 | $7.86M | 3.92% | −523,806−38.0% | Reduced |
| Millennium Management LLC | 933,098 | $8.57M | 0.01% | −425,264−31.3% | Reduced |
| Lion Point Capital, LP | 1,557,233 | $11.2M | 4.52% | +608,663+64.2% | Added |
| Morgan Stanley | 1,240,273 | $11.4M | 0.00% | −77,900−5.9% | Reduced |
| Novo Holdings A/S | 2,000,000 | $18.4M | 0.88% | −530,003−20.9% | Reduced |
| Ra Capital Management, L.P. | 2,246,503 | $20.6M | 0.44% | 00.0% | Unchanged |
| VR Adviser, LLC | 2,425,737 | $22.3M | 3.44% | +2,425,737 | New |
| RTW Investments, LP | 4,315,102 | $39.7M | 0.91% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,817,521−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −13,717−100.0% | Sold out |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |